Oaktree Specialty Lending logo
Oaktree Specialty Lending
OCSL | NASDAQ
Chart Builder DCF Calculator
$12.03
-$0.13 (-1.07%)
At close: Nov 16, 2026, 4:00 PM ET
$11.79
-$0.24 (-2.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Oaktree Specialty Lending Company Profile

Company profile explained

Company Profile

Oaktree Specialty Lending Corporation (OCSL) functions as a business development company (BDC), dedicated to providing capital solutions for middle-market businesses. Its investment strategy involves a diverse array of financing types, including interim bridge loans, various tiers of secured debt (first and second lien, senior and junior), unsecured loans, hybrid mezzanine debt, and preferred equity stakes. These funds are primarily deployed to support growth initiatives such as corporate expansions, acquisitions led by private equity sponsors, and management buyouts within small and mid-sized enterprises. OCSL actively seeks opportunities across a broad spectrum of industries, including education, general business services, retail and consumer products, healthcare, manufacturing, the food and restaurant sector, construction and engineering, and media and advertising. Individual investments typically range from $5 million to $75 million, predominantly structured as integrated ("one-stop"), first-lien, or second-lien debt facilities, with the potential for a complementary equity co-investment. The target companies generally possess an enterprise value between $20 million and $150 million, and generate operating cash flow (EBITDA) of $3 million to $50 million. While the fund can commit up to $75 million per investment, it has the capacity to originate and underwrite larger transactions, up to $100 million. OCSL primarily concentrates its investment activities within the North American market and aims to serve as the lead investor in its portfolio companies.

Key Executives

Name Position
Armen Panossian Chief Executive Officer & Co-Chief Investment Officer
Brett McKeone Chief Operating Officer
Aman Kumar Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending
Ashley Pak Chief Compliance Officer
Christopher McKown CFO & Treasurer
Dane Kleven Senior Vice President & Head of Investor Relations
Eric Johnson Managing Director
Mary Gallegly MD,General Counsel & Secretary
Mathew Pendo President
Raghav Khanna Co-Chief Investment Officer
Sandeep Kumar Khorana Managing Director of Origination

Latest SEC Filings

Date Type Title
Oct 23, 2026 40-17G Filing
Sep 16, 2026 8-K Current Report
Sep 11, 2026 8-K Current Report
Sep 11, 2026 424B2 Filing
Sep 10, 2026 497AD Filing
Sep 09, 2026 FWP Filing
Sep 09, 2026 424B2 Filing
Aug 13, 2026 4 Filing
Aug 05, 2026 8-K Current Report
Aug 05, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Oaktree Specialty Lending
Oaktree Specialty Lending logo
Country United States
IPO Date Jun 12, 2008
Industry Asset Management
Sector Financial Services
Employees 0
CEO Armen Panossian

Contact Details

333 South Grand Avenue Los Angeles, California 90071 United States

Stock Details

Ticker Symbol OCSL
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001414932
CUSIP Number 67401P405
ISIN Number US67401P4054
SIC Code

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.